Physician profile
Sheldon Genack
NPI 1821104308
$2,970.00
in general payments reported to CMS, 2019-2025
16 companies · $611 in 2025
The $611 reported for 2025 was more than what 82% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $212 · 2021: $305 · 2022: $365 · 2023: $769 · 2024: $359 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.38 |
| Education | $107.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $484.50 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $430.40 | 2021-2025 | Nucala |
| Genzyme Corporation | $380.17 | 2023-2025 | |
| Optinose US, INC. | $298.42 | 2019-2023 | |
| Alk-Abello, INC | $290.88 | 2019-2025 | Odactra, Ragwitek, Grastek |
| Neurent Medical Limited | $217.68 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Phathom Pharmaceuticals, INC. | $178.04 | 2025 | Voquezna |
| Boston Scientific Corporation | $162.14 | 2022 | |
| Inspire Medical Systems, INC. | $150.10 | 2023 | Inspire |
| Intersect Ent, INC. | $131.67 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $107.94 | 2023-2024 | |
| Abbvie INC. | $52.79 | 2023-2024 | |
| Hikma Pharmaceuticals USA | $41.30 | 2022-2024 | Ryaltris |
| Amgen INC. | $27.49 | 2025 | Tezspire |
| Galderma Laboratories, L.P. | $16.48 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheldon Genack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.